IL-15, Body Composition and Insulin Sensitivity in Aging
IL-15, Body Composition and Insulin Sensitivity in Aging
批准号:
7028440
负责人:
LEBRIS S QUINN
金额:
$19.65万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-15 至 2010-12-31
关键词:
adipose tissueagingbioenergeticsbody compositionbody physical activitycaloric dietary contentcytokine receptorsdietary lipideatinggenetically modified animalsinsulin sensitivity /resistanceinterleukin 15laboratory mousemessenger RNAnutrition related tagobesitypathogenic dietsarcopeniastriated muscles
中文摘要
描述(申请人提供):人类和啮齿动物的正常衰老的特征是骨骼肌量减少(称为骨质疏松症),以及白色脂肪组织质量的增加,导致脂肪:精瘦身体组成比增加。这些变化的后果是与年龄相关的肥胖、心血管疾病、胰岛素抵抗、2型糖尿病和身体虚弱的发生率增加。通过识别脂肪组织产生的调节包括肌肉在内的其他组织的因子,最近在理解荷尔蒙对身体成分的控制方面取得了进展。肌肉分泌的因子影响脂肪组织的相互信号通路尚未被证实。白介素15(IL-15)是一种合成代谢细胞因子,其主要表达部位为骨骼肌。来自我的实验室的数据表明,IL-15抑制肌肉萎缩,减少脂肪组织质量,并刺激胰岛素敏化激素脂联素的分泌。这项拟议的研究将检验这样一种假设,即肌肉分泌的IL-15会随着年龄的增长而下降,肌肉组织保持IL-15的分泌将抑制与年龄相关的脂肪变化:瘦的身体成分和对胰岛素抵抗的敏感性。这项拟议的研究将利用两种转基因小鼠,其中IL-15通过肌肉特异性启动子过表达,以及正常衰老的小鼠。1.研究正常小鼠衰老过程中肌肉IL-15的表达/分泌、血清IL-15浓度以及肌肉和脂肪组织中IL-15受体mRNA表达的变化。2.确定小鼠肌肉特异性IL-15的过度表达和/或过度分泌是否抑制白色脂肪组织和骨骼肌群与年龄相关的变化。3.确定小鼠肌肉特异性IL-15的过度表达和/或过度分泌是否抑制了暴露在高脂肪/高卡路里饮食中的成年和老年小鼠肥胖和/或胰岛素抵抗的发展。4.确定过度表达和/或过度分泌IL-15的成年和老年小鼠在食物消耗、运动活动、代谢率或代谢底物利用方面是否存在差异。相关性:该项目包括基础科学研究,以确定IL-15信号通路的下降是否会导致骨骼肌的损失和脂肪的增加:正常衰老过程中的瘦身体成分。这项研究可能导致改进的诊断、预防或治疗策略,以应对常见的与年龄相关的临床状况,如虚弱、骨质疏松症、肥胖、胰岛素抵抗和2型糖尿病。
英文摘要
DESCRIPTION (provided by applicant): Normal aging in humans and rodents is characterized by reductions-in skeletal muscle mass (termed sarcopenia), as well as by increases in white adipose tissue mass, resulting in an increased fat:lean body composition ratio. Consequences of these changes are age-related increases in the incidence of obesity, cardiovascular disease, insulin resistance, type-2 diabetes, and physical frailty. Recent progress in understanding the hormonal control of body composition has been made through identification of factors produced by adipose tissue which regulate other tissues, including muscle. A reciprocal signaling pathway, in which factors secreted by muscle affect adipose tissue, has not been demonstrated. Interleukin- 15 (IL-15) is an anabolic cytokine whose major site of expression is skeletal muscle. Data from my laboratory indicate IL-15 inhibits muscle wasting, reduces adipose tissue mass, and stimulates secretion of the insulin- sensitizing hormone adiponectin. The proposed study will test the hypothesis that age-related declines in IL- 15 secretion by muscle occur, and that maintenance of IL-15 secretion by muscle tissue will inhibit age- associated changes in fat:lean body composition and susceptibility to insulin resistance. The proposed study will utilize two kinds of transgenic mice in which IL-15 is overexpressed from a muscle-specific promoter, as well as normally aging mice. The specific aims of the project are to: 1. Characterize changes in muscle IL-15 mRNA and protein expression/secretion, serum IL-15 concentrations, and IL-15 receptor mRNA expression in muscle and adipose tissue, during the aging process in normal laboratory mice. 2. Determine if muscle-specific overexpression and/or oversecretion of IL-15 in mice inhibit age- associated changes in white adipose tissue and skeletal muscle mass. 3. Determine if muscle-specific overexpression and/or oversecretion of IL-15 in mice inhibit development of obesity and/or insulin resistance in adult and aged mice exposed to a high-fat/high calorie diet. 4. Determine if adult and aged mice which overexpress and/or oversecrete IL-15 display difference in food consumption, locomotor activity, metabolic rate, or metabolic substrate utilization. RELEVANCE: This project comprises basic science studies to determine if declines in the IL-15 signaling pathway contribute to the loss of skeletal muscle and increases in fat:lean body composition during normal aging. This research may lead to development of improved diagnostic, prevention, or treatment strategies for the common age-associated clinical conditions of frailty, sarcopenia, obesity, insulin resistance, and type-2 diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IL-15 receptor-alpha and IL-15 action in aging skeletal muscle and adipose tissue
-
批准号:8696809
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:LEBRIS S QUINN
-
依托单位:
IL-15 receptor-alpha and IL-15 action in aging skeletal muscle and adipose tissue
-
批准号:8259085
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:LEBRIS S QUINN
-
依托单位:
IL-15 receptor-alpha and IL-15 action in aging skeletal muscle and adipose tissue
-
批准号:8139059
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:LEBRIS S QUINN
-
依托单位:
IL-15 receptor-alpha and IL-15 action in aging skeletal muscle and adipose tissue
-
批准号:8398951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:LEBRIS S QUINN
-
依托单位:
IL-15, Body Compositition and Insulin Sensivity in Aging
-
批准号:7365086
-
项目类别:
-
资助金额:$21.36万
-
财政年份:2006
-
负责人:LEBRIS S QUINN
-
依托单位:
IL-15, Body Compositition and Insulin Sensivity in Aging
-
批准号:7569478
-
项目类别:
-
资助金额:$21.36万
-
财政年份:2006
-
负责人:LEBRIS S QUINN
-
依托单位:
IL-15, Body Composition and Insulin Sensitivity in Aging
-
批准号:7195776
-
项目类别:
-
资助金额:$21.8万
-
财政年份:2006
-
负责人:LEBRIS S QUINN
-
依托单位:
IL-15, Body Compositition and Insulin Sensivity in Aging
-
批准号:7793558
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2006
-
负责人:LEBRIS S QUINN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: